Cutaneous reactive angiomatosis associated with cholesterol embolism.

Cholesterol embolism (CE) is characterized by emboli containing cholesterol crystal in the arterioles, most commonly found in the skin and the kidney. The skin presentations of CE include livedo reticularis, blue toe syndrome, ulceration and gangrene. Cutaneous reactive angiomatosis (CRA) is a recently proposed term to describe a group of reactive vascular proliferation in skin caused by various diseases. Its occurrence in association with CE is extremely uncommon. An 82-year-old man with a history of cerebral infarction and on long-term warfarin therapy developed progressive, multiple violaceous papules and nodules on the dorsal feet, soles and toes, simulating Kaposi's sarcoma. Skin biopsy showed marked vascular endothelial cell proliferations characteristic of CRA affecting the full thickness of dermis. In addition, cholesterol crystal emboli were found in dermal arterioles. The skin lesions improved after the warfarin dose was reduced. We emphasize the possible presence of CE in a patient presented with CRA, especially in those with a pre-existing atherosclerotic disease, on anticoagulation therapy, or having a prior history of invasive vascular procedure.
AuthorsYa-Wen Yang, Chi-Long Chen, Wen-Tsao Ho, Kuo-Hsien Wang
JournalJournal of cutaneous pathology (J Cutan Pathol) Vol. 37 Issue 6 Pg. 692-6 (Jun 2010) ISSN: 1600-0560 [Electronic] Denmark
PMID19614996 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
  • Aged, 80 and over
  • Angiomatosis (complications, pathology)
  • Embolism, Cholesterol (complications, pathology)
  • Humans
  • Male
  • Skin Diseases (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: